Phytopharm plc (LSE: PYM; NASDAQBB: PHYOF; PHYOY) (“Phytopharm”) announces the appointment with immediate effect of Dr Peter Robin Blower, former Director of New Neuroscience products at SmithKline Beecham as a non-executive Board Director of Phytopharm.
